MXPA03002863A - Valoracion de cancer colorrectal. - Google Patents

Valoracion de cancer colorrectal.

Info

Publication number
MXPA03002863A
MXPA03002863A MXPA03002863A MXPA03002863A MXPA03002863A MX PA03002863 A MXPA03002863 A MX PA03002863A MX PA03002863 A MXPA03002863 A MX PA03002863A MX PA03002863 A MXPA03002863 A MX PA03002863A MX PA03002863 A MXPA03002863 A MX PA03002863A
Authority
MX
Mexico
Prior art keywords
colorectal cancer
cancer diagnostics
microarrays
assessing
kits
Prior art date
Application number
MXPA03002863A
Other languages
English (en)
Inventor
Yixin Wang
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA03002863A publication Critical patent/MXPA03002863A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un metodo para valorar la presencia o ausencia de cancer colorrectal o la probable condicion de una persona que se piensa tiene cancer colorrectal, se lleva a cabo analizando la expresion de un grupo de genes; se incluyen perfiles de expresion de genes en una variedad de medios tales como microdisposiciones, como tambien equipos que los contienen.
MXPA03002863A 2002-03-29 2003-03-31 Valoracion de cancer colorrectal. MXPA03002863A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36868702P 2002-03-29 2002-03-29

Publications (1)

Publication Number Publication Date
MXPA03002863A true MXPA03002863A (es) 2004-08-11

Family

ID=28675528

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03002863A MXPA03002863A (es) 2002-03-29 2003-03-31 Valoracion de cancer colorrectal.

Country Status (10)

Country Link
US (1) US20030186303A1 (es)
EP (1) EP1355151A3 (es)
JP (2) JP4354725B2 (es)
KR (1) KR100984996B1 (es)
CN (2) CN101684500A (es)
AR (1) AR039211A1 (es)
AU (1) AU2003203561A1 (es)
BR (1) BR0303012A (es)
CA (1) CA2422305C (es)
MX (1) MXPA03002863A (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2475769C (en) * 2003-08-28 2018-12-11 Veridex, Llc Colorectal cancer prognostics
US20050153352A1 (en) * 2004-01-09 2005-07-14 Stanley Chang Cancer specific gene MG20
NZ563341A (en) * 2005-06-06 2009-10-30 Genentech Inc Methods for identifying agents that modulate a gene that encodes for a PRO1568 polypeptide
EP2319941A3 (en) * 2005-10-21 2011-08-17 GeneNews Inc. Method and apparatus for correlating levels of biomarker products with disease
MX2008011356A (es) * 2006-03-03 2008-09-15 Veridex Llc Prueba molecular para predecir la recurrencia del cancer de colon de la etapa b de duke.
EP2657352A3 (en) * 2007-10-23 2014-01-22 Clinical Genomics Pty Ltd A method of diagnosing neoplasms - II
EP2169078A1 (en) 2008-09-26 2010-03-31 Fundacion Gaiker Methods and kits for the diagnosis and the staging of colorectal cancer
WO2013092960A1 (en) 2011-12-22 2013-06-27 Fundacion Gaiker Methods and kits for the diagnosis of colorectal cancer
CN102586420B (zh) * 2011-12-27 2014-10-22 盛司潼 一种检测乳腺癌易感基因的方法及试剂盒
CN102586423B (zh) * 2011-12-27 2015-01-07 盛司潼 一种检测结直肠癌易感基因的方法及试剂盒
CN115678994A (zh) * 2022-01-27 2023-02-03 上海爱谱蒂康生物科技有限公司 一种生物标志物组合、含其的试剂及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US635152A (en) * 1899-06-05 1899-10-17 Melancthon S Shotwell Car-body bolster.
US6275814B1 (en) * 1996-11-27 2001-08-14 Investment Strategies Network Investment portfolio selection system and method
US6003018A (en) * 1998-03-27 1999-12-14 Michaud Partners Llp Portfolio optimization by means of resampled efficient frontiers
US6350578B1 (en) * 1999-06-25 2002-02-26 The Regents Of The University Of California Method of quantitating dsDNA
US6175824B1 (en) * 1999-07-14 2001-01-16 Chi Research, Inc. Method and apparatus for choosing a stock portfolio, based on patent indicators

Also Published As

Publication number Publication date
CA2422305A1 (en) 2003-09-29
KR100984996B1 (ko) 2010-10-04
CN1502989A (zh) 2004-06-09
AU2003203561A1 (en) 2003-10-23
JP2009153521A (ja) 2009-07-16
AR039211A1 (es) 2005-02-09
KR20030078801A (ko) 2003-10-08
CN101684500A (zh) 2010-03-31
EP1355151A3 (en) 2004-08-25
EP1355151A2 (en) 2003-10-22
JP4354725B2 (ja) 2009-10-28
CA2422305C (en) 2013-07-30
US20030186303A1 (en) 2003-10-02
BR0303012A (pt) 2004-09-08
JP2003325191A (ja) 2003-11-18

Similar Documents

Publication Publication Date Title
EP1526186A3 (en) Colorectal cancer prognostics
WO2006060653A3 (en) Lung cancer prognostics
WO2004066941A3 (en) Expression profiles for colon cancer and methods of use
MXPA04003931A (es) Pronostico de cancer de mama.
WO2005083429A3 (en) Breast cancer prognostics
EP2392678A3 (en) Prognosis prediction for colorectal cancer
MXPA03002863A (es) Valoracion de cancer colorrectal.
WO2005005601A3 (en) Compositions and methods for treating and diagnosing cancer
MXPA03002862A (es) Panel de diagnostico del cancer.
WO2006138275A3 (en) Compositions and methods for treating and diagnosing cancer
TW200600785A (en) Method for diagnosing non-small cell lung cancer
WO2006012646A3 (en) Amacr cancer markers
EP1476562A4 (en) OVEREXPRESSION OF EXTREMOZYME GENES IN PSEUDOMONAL BACTERIA AND CLOSELY BOUNDED BACTERIA
MXPA03002866A (es) Valoracion de cancer colorrectal.
WO2005059108A3 (en) Gene expression profiles and methods of use
WO2006135886A3 (en) Compositions and methods for treating and diagnosing cancer
WO2007087612A3 (en) Detection and diagnosis of smoking related cancers
AU2003223367A8 (en) Method and compositions for the diagnosis and treatment of non-small cell lung cancer using gene expression profiles
EP2333112A3 (en) Breast cancer prognostics
WO2005032495A3 (en) Gene expression profiles and methods of use
ATE483979T1 (de) Gen anln in verbindung mit nicht-kleinzelligem lungenkrebs und seine wechselwirkungen mit rhoa
IL180129A0 (en) Identifying chromosomal abnormalities in cells obtained from follicular fluid
SI1730315T1 (sl) Polimorfizmi v genu NOD2/CARD15
MXPA03002864A (es) Portafolios de pronostico de cancer de mama.
MXPA05004971A (es) Pronostico para malignidad hematologica.

Legal Events

Date Code Title Description
FG Grant or registration